Concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer

Medical Oncology

Volumn 24, Issue 2, 2007, Pages 239-243

  Cengiz, Mustafa ^a   Zorlu, Faruk ^a   Yalcin, Suayip ^a   Gurkaynak, Murat ^a   Atahan, I Lale ^a   Gullu, Ibrahim H ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Chemotherapy; Concomitant chemoradiotherapy; Gemcitabine; Pancreas cancer; Radiotherapy

Indexed keywords

ANTIEMETIC AGENT; CISPLATIN; CONTRAST MEDIUM; DECORT; DEXAMETHASONE; FLUOROURACIL; GEMCITABINE; METOCLOPRAMIDE; UNCLASSIFIED DRUG;

ABDOMINAL DISCOMFORT; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG WITHDRAWAL; EPIGASTRIC PAIN; FEMALE; GASTRITIS; HUMAN; HUMAN TISSUE; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; PANCREAS CANCER; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT RESPONSE; VOMITING;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; DEOXYCYTIDINE; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PROSPECTIVE STUDIES; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY; SURVIVAL RATE;

EID: 36248962145     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02698046     Document Type: Article

References (13)

1. Evans DB, Abbruzzese JL, Willet CG: Cancer of the pancreas. In: DeVita VT, Hellman S, Rosenberg SA (eds). Cancer: principles and practice of oncology. 6th ed. Lippincott-Raven: Philadelphia, 2001, pp 1054-1087.
2. Moertel CG, et al. Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads+5 fluorouracil), and high dose radiation + 5 fluorouracil. Cancer 1981;48:1705-1710.
3. Gastrointestinal Tumor Study Group. Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. J Natl Cancer Inst 1988;80(10):751-755.
4. Epelbaum R, et al. Phase II study of gemcitabine combined with radiation therapy in patients with localized, unresectable pancreatic cancer. J Surg Oncol 2002;81:138-143.
5. Miller AB, Hoogstraten B, Straquet M. Reporting results of cancer treatment. Cancer 1981;147:207-214.
6. McCracken JD, et al. 5-Fluorouracil, methylCCNU, and radiotherapy with or without testolactone for localized adenocarcinomas of the exocrine pancreas. A Southwest Oncology Group Study. Cancer 1980;46:1518-1522.
7. The Gastrointestinal Tumor Study Group. Radiation therapy combined with adriamycin or 5-fluorouracil for the treatment of locally unresectable pancreatic carcinoma. Cancer 1985;56:2563-2568.
8. Lawrence TS, Chang EY, Hahn TM, Hertel LW, Shewash DS. Radiosensitization of pancreatic cancer cells by 2,2-difluoro-2-deoxycytidine. Int J Radiat Oncol Biol Phys 1996;54(4):867-872.
9. Milas L, et al. Enhancement of tumor radioresponse in vivo by gemcitabine. Cancer Res 1999;59:107-114.
10. McGinn C, et al. A phase I study of gemcitabine in combination with radiation therapy in patients with localized, unresectable pancreatic cancer. (Abstract 283a) Proc Am Soc Clin Oncol 1998;17:264.
11. Wolff RA, et al. Phase I trial of gemcitabine combined with radiation for treatment of locally advanced pancreatic adenocarcinoma. Clin Cancer Res 2001;7:2246-2253.
12. Crane CH, et al. Toxicity and efficiacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer. Int J Pancreatol 2001;29(1):9-18.
13. Yavuz AA, Aydin F, Yavuz MN, Ilis E, Ozdemir F.. Radiation therapy and concurrent fixed dose amifostine with escalating doses of twice-weekly gemcitabine in advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 2001;51(4):974-981.